48. 原発性抗リン脂質抗体症候群 Primary antiphospholipid syndrome Clinical trials / Disease details


臨床試験数 : 5 薬物数 : 6 - (DrugBank : 4) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 7

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05671757
(ClinicalTrials.gov)
March 12, 202320/12/2022Daratumumab in Primary Antiphospholipid SyndromeTargeting CD38 With Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial (ITN093AI)Autoimmune DisordersBiological: DaratumumabNational Institute of Allergy and Infectious Diseases (NIAID)Immune Tolerance Network (ITN);PPD;Rho Federal Systems Division, Inc.Not yet recruiting18 Years65 YearsAll22Phase 1/Phase 2United States